EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hepatic-Specific FGF21 Knockout Abrogates Ovariectomy-Induced Obesity by Reversing Corticosterone Production

Jiayu Xu, Xinyu Shao, Haozhe Zeng, Chengxi Wang, Jiayi Li, Xiaoqin Peng, Yong Zhuo iD, Lun Hua, Fengyan Meng, Xingfa Han

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms241914922 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Jiayu Xu und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Science, Sichuan Agricultural University, Ya'an 625014, China. Hauptthemen laut MEDLINE: Insulin Resistance, Metabolic Syndrome. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Department of Sichuan Province, science foundation project from the Science and Technology Department of Sichuan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Increased glucocorticoid (GC) levels act as a master contributor to central obesity in estrogen-depleted females; however, what factors cause their increased GC production is unclear. Given (1) liver fibroblast growth factor 21 (FGF21) and GCs regulate each other’s production in a feed-forward loop, and (2) circulating FGF21 and GCs are parallelly increased in menopausal women and ovariectomized mice, we thus hypothesized that elevation of hepatic FGF21 secretion causes increased GGs production in estrogen-depleted females. Using the ovariectomized mice as a model for menopausal women, we found that ovariectomy (OVX) increased circulating corticosterone levels, which in turn increased visceral adipose Hsd11b1 expression, thus causing visceral obesity in females. In contrast, liver-specific FGF21 knockout (FGF21 LKO) completely reversed OVX-induced high GCs and high visceral adipose Hsd11b1 expression, thus abrogating OVX-induced obesity in females. Even though FGF21 LKO failed to rescue OVX-induced dyslipidemia, hepatic steatosis, and insulin resistance. What’s worse, FGF21 LKO even further exacerbated whole-body glucose metabolic dysfunction as evidenced by more impaired glucose and pyruvate tolerance and worsened insulin resistance. Mechanically, we found that FGF21 LKO reduced circulating insulin levels, thus causing the dissociation between decreased central obesity and the improvement of obesity-related metabolic syndromes in OVX mice. Collectively, our results suggest that liver FGF21 plays an essential role in mediating OVX-induced central obesity by promoting GC production. However, lack of liver FGF21 signaling reduces insulin production and in turn causes the dissociation between decreased central obesity and the improvement of obesity-related metabolic syndromes, highlighting a detrimental role for hepatic FGF21 signals in mediating the development of central obesity but a beneficial role in preventing metabolic abnormality from further exacerbation in estrogen-depleted females.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Insulin ResistanceMetabolic SyndromeHumansFemaleMiceAnimalsCorticosteroneObesity, AbdominalMice, KnockoutLiverObesityFibroblast Growth FactorsGlucocorticoidsGlucoseInsulinEstrogensOvariectomyDiet, High-Fat

Stichwörter der Autor:innen

FGF21central obesitycorticosteroneinsulinmetabolic syndromesoveriectomy

Substanzen

fibroblast growth factor 21CorticosteroneFibroblast Growth FactorsGlucocorticoidsGlucoseInsulinEstrogens

Autor:innen und Institutionen

  • College of Life Science, Sichuan Agricultural University, Ya'an 625014, China.
  • Institute of Animal Nutrition, Sichuan Agricultural University, Chengdu 611134, China.

ORCID-Profile: Yong Zhuo

Förderung

  • Science and Technology Department of Sichuan Province
  • science foundation project from the Science and Technology Department of Sichuan Province

Zitieren

APA

Xu, J., Shao, X., Zeng, H., Wang, C., Li, J., Peng, X., Zhuo, Y., Hua, L., Meng, F., & Han, X. (2023). Hepatic-Specific FGF21 Knockout Abrogates Ovariectomy-Induced Obesity by Reversing Corticosterone Production. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241914922

Vancouver

Xu J, Shao X, Zeng H, Wang C, Li J, Peng X, et al. Hepatic-Specific FGF21 Knockout Abrogates Ovariectomy-Induced Obesity by Reversing Corticosterone Production. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241914922

BibTeX
@article{Xu2023,
  author = {Xu, Jiayu and Shao, Xinyu and Zeng, Haozhe and Wang, Chengxi and Li, Jiayi and Peng, Xiaoqin and Zhuo, Yong and Hua, Lun and Meng, Fengyan and Han, Xingfa},
  title = {Hepatic-Specific FGF21 Knockout Abrogates Ovariectomy-Induced Obesity by Reversing Corticosterone Production},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms241914922}
}
Kostenlos starten →